cn.pudeepharm.com

pudeepharm.com

143-66-8,Sodium tetraphenylboron,C24H20Bna,Tetraphenylboron tetraphenylphosphonium,15525-15-2,Resins,catalyst

http://www.pudeepharm.com/Sodium-tetraphenylboron-40.html

Sodium tetraphenylboron - Detail. An important material to synthesize liquid crystalline resins. used as catalyst sometime. The key material forTetraphenylboron tetraphenylphosphonium (15525-15-2), white crystalline powder. Purity 99.5% , packing size 25kg/drum. 2,4-DIAMINO-6-[2-(2-METHYL-1-IMIDAZOLYL)ETHYL]-1,3,5-TRIAZINE.

pudeepharm.com

About us Suzhou Pudee BioPharmaceutical Co., Ltd.

http://www.pudeepharm.com/about_us

Suzhou Pudee BioPharmaceutical Co., Ltd. is a reliable growing company rich in advanced technology, creativity and experience. Since the year of 2003, the company has been involved in the fields of bio-medicine and synthetic drugs. Nowadays, it has become a specialized manufacturer and supplier of advanced and key pharmaceutical intermediates and relevant API. The core R&D team is made up of 7 experienced and creative professional doctors and 2 elite engineering technicians.

pudeepharm.com

Bortezomib intermediate,179324-87-9,Bortezomib,179324-69-7,PS-341,Velcade,Anti-cancer,proteasome inhibitor,multiple myeloma,Neomib,Bortecad,C19H25BN4O4,C15H28BNO2.C2HF3O2

http://www.pudeepharm.com/Pinanediol-CF3COOH-17.html

AR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate. Bortezomib Intermediate - Detail. Is the first therapeutic. To be tested in humans. It is approved in the U.S. for treating relapsed. In multiple myeloma, complete clinical responses have been obtained in patients with otherwise refractory or rapidly advancing disease. It was originally synthesized in 1995 at Myogenics and was approved in the United States by the.

pudeepharm.com

Intermediates

http://www.pudeepharm.com/Intermediates-c2-page1.html

Suzhou Pudee Biopharm. Co., Ltd, is a specialized and experienced manufacturer and supplier of advanced pharmaceutical intermediates and relevant API. we provide excellent products for global users at a attractive and competitive price. in order to the patients can share the efforts of medical technology progress and consume the quality and safe medicine at a affordable price. we are willing to assist the downstream manufacturers to reduce their costs directly.

pudeepharm.com

R&D and IPR Suzhou Pudee Bio-Pharmaceutical Co., Ltd.

http://www.pudeepharm.com/abouts/r-d.html

Our core R&D team consists of quite a few of doctors. All knock out products and core processes are ptotected by patent right.Up to now,several patents. Both at home and abroad have been applied.

pudeepharm.com

Suzhou Pudee Bio-Pharmaceutical Co., Ltd.

http://www.pudeepharm.com/products

Suzhou Pudee Bio-Pharmaceutical Co., Ltd. is a reliable growing company rich in advanced technology, creativity and experience. Since the year of 2003, the company has been involved in the fields of bio-medicine and synthetic drugs. Nowadays, it has become a specialized manufacturer and supplier of advanced and key pharmaceutical intermediates and relevant API. The core R&D team is made up of 7 experienced and creative professional doctors and 2 elite engineering technicians.

pudeepharm.com

Nilotinib intermediate,641571-11-1,Nilotinib,641571-10-0, 641569-94-0,AMN107,Tasigna,C28H22F3N7O,C11H10F3N3,C17H14N4O2, imatinib, leukemia,Philadelphia Chromosome (Ph+),gastrointestinal stromal tumor

http://www.pudeepharm.com/aniline-19.html

Philadelphia Chromosome (Ph ). Nilotinib Intermediate - Detail. It was developed based on the structure of the Abl-imatinib complex to address imatinib intolerance and resistance. Nilotinib is a selective Bcr-Abl kinase inhibitor that is 10-30 fold more potent than imatinib in inhibiting Bcr-Abl tyrosine kinase activity and. Of Bcr-Abl expressing cells. It is approved by. 29 October 2007),. 29 September 2009),. 19 November 2007) and. 17 January 2008) for use as a treatment for. We can provide the key.

pudeepharm.com

API- a specialized manufacturer and supplier

http://www.pudeepharm.com/API-c1-page1.html

Suzhou Pudee Biopharm. Co., Ltd, is a specialized and experienced manufacturer and supplier of advanced pharmaceutical intermediates and relevant API. we provide excellent products for global users at a attractive and competitive price. in order to the patients can share the efforts of medical technology progress and consume the quality and safe medicine at a affordable price. we are willing to assist the downstream manufacturers to reduce their costs directly. Prostaglandin F2a tris salt.

pudeepharm.com

83494-32-0,Difluoromethylthioacetic acid,C3H4F2O2S,Flomoxef,Flomoxef lateral chain,Antibiotic, 99665-00-6

http://www.pudeepharm.com/Difluoromethylthioacetic-acid-26.html

Difluoromethylthioacetic acid - Detail. Flomoxef is a broad-spectrum cephalosporin oxygen ene (oxa cephalosporin) antibiotic, the β-lactamase is very stable, Difluoromethylthioacetic acid is one lateral chain of Flomoxef ( 99665-00-6 ). Potassium salt form is provided . Its appearance is off-white crystalline powder. Assay ( GC ) 98% , The minimum order quantity is 500 g. Packing size : 500g/bag, 1kg/bag, 10kg/drum, 25kg/drum. 1s,2s,3R,5S) pinanediol.